• Insmed Research Award Created for Non-Tuberculosis Mycobacteria Lung Disease Projects
  • NIH Agency Pioneers Collaborative Research into Rare Diseases
  • Severe Asthma Patients with Bronchiectasis at Increased Risk of Hospitalization, Other Issues, Study Finds
  • European Regulators Agree to Review Aradigm’s Bronchiectasis Bacteria Therapy
  • Bronchiectasis Patients with P. Aeruginosa Show Worse Lung Function, Lower Quality of Life in Study
  • New Scoring System Helps Predict Bronchiectasis in Patients with Uncontrolled Asthma, Study Shows
  • Airway Abnormality, Immunodeficiency Are Key Causes of Non-CF Bronchiectasis in Turkey, Study Finds
  • Genome Sequencing and Its Clinical Potential Focus of NYC Rare Disease Day Event
  • ‘A Disease May Be Rare, Hope Should Never Be,’ Says Boy with SMARD at Connecticut Rare Disease Day Event
  • Aradigm Asks EU to Approve Linhaliq for Bronchiectasis Patients’ Bacterial Infections
  • Rare Disease Groups Welcome FDA’s Embrace of ‘Real World’ Data in Clinical Trials
  • US Lawmakers Urge Bipartisan Support for Rare Disease Research, Patients’ Needs